US firm Brownstein nabs five from Crowell ‘at pivotal moment’

Three of the new shareholders have IP and life sciences expertise, bringing a commercial and policy focus to the firm.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Careers

Orrick adds specialist licensing partner in Silicon Valley

12 March 2026 With life sciences companies increasingly reliant on complex IP and licensing deals, the firm’s new hire is set to strengthen its technology transactions practice.

Careers

Arnold & Porter adds tech litigator in San Francisco

10 March 2026 New counsel joins the firm from Kirkland & Ellis, bringing more than a decade of experience across advanced technology sectors.

Careers

DWT recruits first-chair trial litigator as latest hire in IP expansion

4 March 2026 As the firm expands its IP offering, “an unusually versatile lawyer” with chemical, biologics, and medical device spaces expertise joins the New York office.

More features

Mylan withdraws defence claims against Novo in Wegovy dispute

INTA: ‘New normal’ for in-house counsel as budgets fall

Six Summit takeaways: In-person IP, agentic AI and ‘infollution’ risks

Astellas blocks generic version of key urology drug until 2030

Orrick adds specialist licensing partner in Silicon Valley

GSK inks licensing deal for liver disease drug

Arnold & Porter adds tech litigator in San Francisco

Novo ends Hims & Hers dispute with deal for blockbuster weight-loss drugs

US firm Brownstein nabs five from Crowell ‘at pivotal moment’

More on this story

Editor's picks

Editor's picks

More features